Bariatric surgery and diabetes remission: how far have we progressed?

被引:0
作者
Singh, Awadhesh Kumar [1 ]
Kota, Sunil Kumar [2 ]
机构
[1] GD Hosp & Diabet Inst, Kolkata, W Bengal, India
[2] Diabet & Endocare Clin, Berhampur, Odisa, India
关键词
bariatric surgery; diabetes remission; ghrelin; incretin; Type; 2; diabetes;
D O I
10.1586/17446651.2015.1073586
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity and type 2 diabetes mellitus have been associated with higher morbidity and mortality. Bariatric surgery results in substantial and sustained weight loss in morbidly obese patients and improves obstructive sleep apnea. Furthermore, bariatric surgery improves diabetes control, hypertension, quality of life, stroke, myocardial infarction and reduces mortality. Interestingly, bariatric surgery induces high rates of short and long-term diabetes remission. While the exact mechanisms behind this are not completely understood, improved insulin action, beta-cell function and a complex interplay of hormones in the entero-insular axis appear to play major roles. Insulin action improves proportionally to weight loss and it gets completely normalized especially after bilio-pancreatic diversion. beta-Cell function also seems to improve after a variety of bariatric surgeries. Seemingly, baseline beta-cell function is able to predict future diabetes remission. This article will review the effectiveness of bariatric procedures on the remission and improvement of diabetes and its implicated mechanisms.
引用
收藏
页码:545 / 559
页数:15
相关论文
共 134 条
  • [1] Standards of Medical Care in Diabetes-2013
    不详
    [J]. DIABETES CARE, 2013, 36 : S11 - S66
  • [2] Standards of Medical Care in Diabetes-2009
    不详
    [J]. DIABETES CARE, 2009, 32 : S13 - S61
  • [3] What can bariatric surgery teach us about the pathophysiology of type 2 diabetes?
    Andreelli, F.
    Amouyal, C.
    Magnan, C.
    Mithieux, G.
    [J]. DIABETES & METABOLISM, 2009, 35 (06) : 499 - 507
  • [4] Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial
    Angrisani, Luigi
    Lorenzo, Michele
    Borrelli, Vincenzo
    [J]. SURGERY FOR OBESITY AND RELATED DISEASES, 2007, 3 (02) : 127 - 132
  • [5] [Anonymous], 2006, J CLIN ENDOCR METAB, V91, P1735
  • [6] A Multisite Study of Long-term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass
    Arterburn, David E.
    Bogart, Andy
    Sherwood, Nancy E.
    Sidney, Stephen
    Coleman, Karen J.
    Haneuse, Sebastien
    O'Connor, Patrick J.
    Theis, Mary Kay
    Campos, Guilherme M.
    McCulloch, David
    Selby, Joe
    [J]. OBESITY SURGERY, 2013, 23 (01) : 93 - 102
  • [7] Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass
    Ashrafian, H.
    Athanasiou, T.
    Li, J. V.
    Bueter, M.
    Ahmed, K.
    Nagpal, K.
    Holmes, E.
    Darzi, A.
    Bloom, S. R.
    [J]. OBESITY REVIEWS, 2011, 12 (501) : e257 - e272
  • [8] Astiarraga B, J CLIN ENDOCRINOL ME
  • [9] Nutritional deficiencies after bariatric surgery
    Bal, Bikram S.
    Finelli, Frederick C.
    Shope, Timothy R.
    Koch, Timothy R.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (09) : 544 - 556
  • [10] Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery
    Ballantyne, Garth H.
    [J]. OBESITY SURGERY, 2006, 16 (06) : 795 - 803